Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial is a research paper published in Tomography (2020). On theSindex it has a DataRank of 0.434. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.434
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: U01 CA151235
NCI NIH HHS
Grant: R01 CA227763
NCI NIH HHS
Grant: R01 CA132870
NCI NIH HHS
Grant: U01 CA225427
National Institutes of Health
Grant: 5U01CA225427-02
Quantitative Imaging for Assessing Breast Cancer Response to Treatment
National Institutes of Health
Grant: 5R01CA132870-10
Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-Operative Treatment Trials
FWCI
0.82
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals